PlainRecalls
FDA Drug Moderate Class II Completed

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Reported: May 25, 2022 Initiated: April 5, 2022 #D-0884-2022

Product Description

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Reason for Recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Details

Recalling Firm
Cardinal Health Inc.
Units Affected
1 box
Distribution
NM only
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80. Recalled by Cardinal Health Inc.. Units affected: 1 box.
Why was this product recalled?
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
Which agency issued this recall?
This recall was issued by the FDA Drug on May 25, 2022. Severity: Moderate. Recall number: D-0884-2022.